Benzinga | Jul 30, 2020 04:25PM EDT

Infinity Pharmaceuticals Q2 EPS $(0.16) Beats $(0.19) Estimate, Sales $360.00K Beat $160.00K Estimate

Infinity Pharmaceuticals (NASDAQ:INFI) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 11.11 percent increase over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $360.00 thousand which beat the analyst consensus estimate of $160.00 thousand by 125.00 percent. This is a 40.08 percent increase over sales of $257.00 thousand the same period last year.